Omega-3 polyunsaturated fatty acids in atrial fibrillation prevention after coronary bypass surgery
Aim. To assess omega-3-polyunsaturated fatty acids (w-3-PUFA) effects on atrial arrhythmogenicity in patients with coronary heart disease, who underwent coronary bypass surgery (CBS). Material and methods. In total, 50 patients, who underwent CBS, were examined. All participants were divided into tw...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-04-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1192 |
| _version_ | 1827064108993740800 |
|---|---|
| author | B. A. Tatarsky |
| author_facet | B. A. Tatarsky |
| author_sort | B. A. Tatarsky |
| collection | DOAJ |
| description | Aim. To assess omega-3-polyunsaturated fatty acids (w-3-PUFA) effects on atrial arrhythmogenicity in patients with coronary heart disease, who underwent coronary bypass surgery (CBS). Material and methods. In total, 50 patients, who underwent CBS, were examined. All participants were divided into two groups. Group I included 25 patients with atrial fibrillation (AF) episodes in anamnesis, who were administered w-3-PUFA (2 g/d) one week before and 7 days after CBS. Group II, control group, included 25 patients without AF in anamnesis, who did not receive w-3-PUFA. Atrial conduction abnormalities were registered by non-invasive, high-definition transesophageal electrocardiography. Results. In Group II, 7 AF cases (28%) were registered during early post-CBS period. AF paroxysm incidence was maximal in the first two days after CBS. In Group I, AF paroxysms were registered in 4 patients (16%), on Day 2-3 after CBS. Clinical symptoms were less severe in Group I than in Group II: in the former, two patients had asymptomatic AF episodes. No AF cases required cardioversion, terminating spontaneously. Group I patients demonstrated increased right and left atrium conductivity. Conclusion. In patients with post4CBS AF risk, w-3-PUFA therapy was associated with arrhythmia risk reduction, pontaneously terminating AF episodes, and less severe hemodynamic disturbances. Adding w-3-PUFA to standard therapy is effective and safe in CBS patients. |
| first_indexed | 2024-04-10T03:40:49Z |
| format | Article |
| id | doaj.art-b0a2f9a3d3dc4f56824d7b387e1dd80f |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2025-03-19T22:41:55Z |
| publishDate | 2007-04-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-b0a2f9a3d3dc4f56824d7b387e1dd80f2024-10-17T12:21:25Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252007-04-01625258904Omega-3 polyunsaturated fatty acids in atrial fibrillation prevention after coronary bypass surgeryB. A. Tatarsky0V.A. Almazov Research Institute of Cardiology, Federal State Agency for Health and Social Development. St. PetersburgAim. To assess omega-3-polyunsaturated fatty acids (w-3-PUFA) effects on atrial arrhythmogenicity in patients with coronary heart disease, who underwent coronary bypass surgery (CBS). Material and methods. In total, 50 patients, who underwent CBS, were examined. All participants were divided into two groups. Group I included 25 patients with atrial fibrillation (AF) episodes in anamnesis, who were administered w-3-PUFA (2 g/d) one week before and 7 days after CBS. Group II, control group, included 25 patients without AF in anamnesis, who did not receive w-3-PUFA. Atrial conduction abnormalities were registered by non-invasive, high-definition transesophageal electrocardiography. Results. In Group II, 7 AF cases (28%) were registered during early post-CBS period. AF paroxysm incidence was maximal in the first two days after CBS. In Group I, AF paroxysms were registered in 4 patients (16%), on Day 2-3 after CBS. Clinical symptoms were less severe in Group I than in Group II: in the former, two patients had asymptomatic AF episodes. No AF cases required cardioversion, terminating spontaneously. Group I patients demonstrated increased right and left atrium conductivity. Conclusion. In patients with post4CBS AF risk, w-3-PUFA therapy was associated with arrhythmia risk reduction, pontaneously terminating AF episodes, and less severe hemodynamic disturbances. Adding w-3-PUFA to standard therapy is effective and safe in CBS patients.https://cardiovascular.elpub.ru/jour/article/view/1192ω-3-polyunsaturated fatty acidscoronary heart diseasecoronary bypass surgerypost-surgery atrial fibrillation |
| spellingShingle | B. A. Tatarsky Omega-3 polyunsaturated fatty acids in atrial fibrillation prevention after coronary bypass surgery Кардиоваскулярная терапия и профилактика ω-3-polyunsaturated fatty acids coronary heart disease coronary bypass surgery post-surgery atrial fibrillation |
| title | Omega-3 polyunsaturated fatty acids in atrial fibrillation prevention after coronary bypass surgery |
| title_full | Omega-3 polyunsaturated fatty acids in atrial fibrillation prevention after coronary bypass surgery |
| title_fullStr | Omega-3 polyunsaturated fatty acids in atrial fibrillation prevention after coronary bypass surgery |
| title_full_unstemmed | Omega-3 polyunsaturated fatty acids in atrial fibrillation prevention after coronary bypass surgery |
| title_short | Omega-3 polyunsaturated fatty acids in atrial fibrillation prevention after coronary bypass surgery |
| title_sort | omega 3 polyunsaturated fatty acids in atrial fibrillation prevention after coronary bypass surgery |
| topic | ω-3-polyunsaturated fatty acids coronary heart disease coronary bypass surgery post-surgery atrial fibrillation |
| url | https://cardiovascular.elpub.ru/jour/article/view/1192 |
| work_keys_str_mv | AT batatarsky omega3polyunsaturatedfattyacidsinatrialfibrillationpreventionaftercoronarybypasssurgery |